Perrigo Company (NYSE: PRGO) — Perfil da empresa, notícias e dados financeiros
Perrigo Company provides OTC health and wellness solutions, developing self-care products and generic pharmaceuticals.
Perrigo Company
Perrigo Company (LSE:0Y5E), (NYSE:PRGO) is a player in the healthcare sector, focused on providing over-the-counter (OTC) health and wellness solutions. Its operations span across the development, manufacture, and distribution of self-care products and generic pharmaceuticals, aimed at improving the well-being of consumers. With a portfolio that includes dietary supplements, infant formulas, and topical medications, Perrigo is dedicated to making quality healthcare accessible and affordable. The company's projects are geared towards innovation in health and wellness, aiming to expand its product offerings while adhering to rigorous safety and efficacy standards. Perrigo’s objective is to lead in the self-care market by continually adapting to consumer health needs through research, development, and strategic acquisitions.
Resumo
Operações
Produtos e/ou serviços de Perrigo Company
- Over-the-counter (OTC) healthcare products, including analgesics, cold and allergy remedies, gastrointestinal and smoking cessation products.
- Generic prescription medications targeting a range of conditions from infections to cardiovascular health.
- Dietary supplements offering vitamins, minerals, and nutritional products.
- Infant formula and foods, focusing on nutritional needs for babies and toddlers.
- Animal health products providing over-the-counter remedies and supplements for pets.
- Contract manufacturing services, offering production capabilities for a range of pharmaceutical and nutritional products.
equipe executiva do Perrigo Company
- Albert Ange ManzoneInterim President, Interim CEO & Director
- Eduardo Guarita BezerraExecutive VP & CFO
- Abbie LennoxEVP & Chief Scientific Officer
- Charles AtkinsonExecutive VP, General Counsel & Secretary
- Roberto KhouryExecutive VP & Chief Commercial Officer
- Eric S. JacobsonVice President of Global Investor Relations
- Robert WillisChief Human Resources Officer & Executive VP
- David BallEVP and Chief Brand & Digital Officer
- Matthew WintermanExecutive Vice President of Product Supply, Operations Strategy & Transformation Officer
- Sonia HolliesSenior VP & Treasurer
Histórico de dividendos
Dividendos por ação pagos pela Perrigo Company , por ano fiscal.
| Ano fiscal | Intermediário | Final | Especial | Total |
|---|---|---|---|---|
| FY2026(até o momento) | — | — | — | $0.8700 |
| FY2025 | — | — | — | $1.1600 |
| FY2024 | — | — | — | $1.1040 |
| FY2023 | — | — | — | $1.0920 |
| FY2022 | — | — | — | $1.0400 |
Principais indicadores financeiros
Resultados divulgados pela Perrigo Company , em USD.
- Cap. de mercado
- 2,2 bi
- Receita (TTM)
- 4,1 bi
- P/L
- —
- LPA (diluído, TTM)
- -12.3
- Dividend yield
- 7.3%
- Margem de lucro
- -41.9%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 4,3 bi | 343,3 mi | -1,4 bi | |
| 4,4 bi | 112,9 mi | -171,8 mi | |
| 4,7 bi | 151,9 mi | -12,7 mi | |
| 4,5 bi | 78,9 mi | -140,6 mi |